Advertisement

Functional Neuromodulation, Ltd Company Profile

02:20 EDT 25th May 2013 | BioPortfolio

Founded in Toronto, Ontario in 2010, Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with Alzheimer’s and other memory and cognitive disorders. The Company has received funding from Genesys Capital, Foundation Medical Partners and Medtronic. Functional Neuromodulation has entered into a partnership with Medtronic, under which Medtronic is providing its state-of-the-art DBS devices for the ADvance Study and access to Medtronic’s related device regulatory filings. For more information, visit www.functionalneuromodulation.com.


News Articles [ 272 Associated News Articles listed on BioPortfolio]

Functional Neuromodulation treats first patient using DBS system in US

Functional Neuromodulation has treated the first US patient with a deep brain stimulation (DBS) system in a randomized, double-blind, controlled trial.

Neuromodulation device market poised to reach $7.07B in 6 years

A Transparency Market Research report predicts that the world market for neuromodulation devices will increase from $2.76 bil -More- 

Sacral neuromodulation cost-effective for fecal incontinence

Sacral neuromodulation is less costly than dynamic graciloplasty and artificial bowel sphincter for the treatment of fecal incontinence, show the results of a Dutch health economics study.

NEUROMODULATION DEVICES: WORLD MARKET PROSPECTS 2013-2023

Neuromodulation is one of the fastest growing sectors of the medical device market. Neuromodulation is a rapidly evolving medical technique that provides symptomatic relief through the alteration, or...

Fukuda to distribute Boston Scientific neuromodulation device in Japan

Fukuda Denshi, a manufacturer of medical electronics equipment, has entered into an agreement to market and sell Boston Scientific's neuromodulation device and accessories throughout Japan.

Worldwide neuromodulation device market could hit $6.8B in 4 years

A MarketsandMarkets report forecasts that by 2017, the worldwide neuromodulation device market will be valued at $6.8 billion -More- 

Innovations in Neuromodulation

In "Innovations in Neuromodulation," the International Neuromodulation Society (INS) brings together over 200 entrepreneurs, thought leaders, innovators and investors June 9th to...

NYU Langone establishes unique neuromodulation center

The Department of Neurosurgery at NYU Langone Medical Center has established a unique, multidisciplinary neuromodulation center for the treatment of complex neurological conditions including movement...

PubMed Articles [ 49 Associated PubMed Articles listed on BioPortfolio]

Electrical neuromodulation for patients with cardiac diseases.

In this review we discuss the position of electrical neuromodulation as a safe and reversible adjuvant therapy for treatment of patients with chronic cardiac diseases who have become refractory to con...

Sacral Nerve Modulation in Overactive Bladder.

This article represents a general overview of therapies for urinary urgency, frequency, and overactive bladder, with specific emphasis on sacral neuromodulation. The history of sacral neuromodulation...

Sacral neuromodulation for the treatment of faecal incontinence in a patient with organophosphate poisoning.

Faecal incontinence is a debilitating condition. Sacral neuromodulation may have a role in the treatment of faecal incontinence. We report a case of faecal incontinence secondary to chronic organophos...

Neuromodulation in male chronic pelvic pain syndrome: rationale and practice.

INTRODUCTION: This review explores the treatment of male chronic pelvic pain syndrome (CPPS) (i.e., chronic prostatitis) through the use of neuromodulation, which is the electrical stimulation of the...

Sacral neuromodulation for the management of severe constipation: development of a constipation treatment protocol.

BACKGROUND: Constipation is a common multifactorial gastrointestinal symptom with quality of life implications. Sacral neuromodulation has been used in the management of severe constipation with mixed...

Clinical Trials [ 958 Associated Clinical Trials listed on BioPortfolio]

Neuromodulation Therapy Device for the Treatment of Sleep Apnea

We are looking to test a novel device in the treatment of Obstructive Sleep Apnea (OSA). Rather than using positive pressure to open the airways, we are testing a device that delivers an a...

Percutaneous Neuromodulation Therapy (PNT) With Chronic Low Back Pain Patients

The purpose of this study is to assess the benefits of Percutaneous Neuromodulation Therapy when compared to a reference sham treatment in the treatment of patients who have undergone surg...

Brain Effects of Sacral Neuromodulation

Sacral neuromodulation (SNM) has become an accepted treatment for patients with refractory lower urinary tract dysfunction such as urgency frequency syndrome, urgency incontinence, non-obs...

Ambulatory Urodynamic Evaluation of Sacral Neuromodulation for Non-Obstructive Urinary Retention

Ambulatory Urodynamic measurement on patients with diminished or absent bladder contractility before and after trial with Sacral Neuromodulation therapy.

Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population

This study is being performed to determine the safety and efficacy of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain...

Companies [ 352 Associated Companies listed on BioPortfolio]

Functional Neuromodulation, Ltd

Founded in Toronto, Ontario in 2010, Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of pe...

Functional Neuromodulation, Ltd.

Founded in Toronto, Ontario in 2010, Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of pe...

Advanced Neuromodulation Systems Incorporated ANS

Advanced Neuromodulation Systems, Inc. (NASDAQ: ANSI) is an exciting, high-technology medical device company that is at the center of the dynamic and explosively growing neuromodulation market.Neuromo...

International Neuromodulation Society

The INS is a nonprofit group of clinicians, scientists and engineers dedicated to scientific development and knowledge of neuromodulation, a rapidly growing family of therapies de...

Advanced Neuromodulation Systems

Welcome to Advanced Neuromodulation Systems Successful treatment of a chronic pain or neurological condition begins with expanding your knowledge and exploring your options.Welcome to Advanced Neuromo...

More Information about "Functional Neuromodulation, Ltd" on BioPortfolio

We have published hundreds of Functional Neuromodulation, Ltd news stories on BioPortfolio along with dozens of Functional Neuromodulation, Ltd Clinical Trials and PubMed Articles about Functional Neuromodulation, Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Functional Neuromodulation, Ltd Companies in our database. You can also find out about relevant Functional Neuromodulation, Ltd Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement